Epilepsy and attention-deficit hyperactivity disorder: Links, risks, and challenges

Neuropsychiatric Disease and Treatment

Volumn 12, Issue , 2016, Pages 287-296

  Williams, Amy E ^a   Giust, Julianne M ^a   Kronenberger, William G ^a   Dunn, David W ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ADHD; Children; Epilepsy; Seizure disorder

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; ATOMOXETINE; CARBAMAZEPINE; CLONIDINE; GUANFACINE; METHYLPHENIDATE; PLACEBO; TRICYCLIC ANTIDEPRESSANT AGENT;

ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CARDIOTOXICITY; DECREASED APPETITE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPSY; FATIGUE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INSOMNIA; IRRITABILITY; LIVER DISEASE; MEDICATION COMPLIANCE; META ANALYSIS (TOPIC); MONOTHERAPY; NONHUMAN; PRESCRIPTION; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SEDATION; SEIZURE; SIDE EFFECT; SOMNOLENCE; SYSTEMATIC REVIEW (TOPIC); TIC; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; WEIGHT REDUCTION;

EID: 84958036302     PISSN: None     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S81549     Document Type: Review

References (84)

1. American Psychiatric Association. DSM-5 Task Force. Diagnostic and Statistical Manual of Mental Disorders DSM-5. 5th ed. Washington, DC: American Psychiatric Association; 2013.
2. Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS. Prevalence, recognition, and treatment of attention-deficit/ hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med. 2007;161(9):857-864.
3. Kessler RC, Green JG, Adler LA, et al. Structure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic Scale. Arch Gen Psychiatry. 2010;67(11):1168-1178.
4. Simon V, Czobor P, Balint S, Meszaros A, Bitter I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br JPsychiatry. 2009;194(3):204-211.
5. Polanczyk GV, Willcutt EG, Salum GA, Kieling C, Rohde LA. ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. Int J Epidemiol. 2014;43(2):434-442.
6. Mash EJ, Barkley RA. Child Psychopathology. New York: Guilford Press; 1996.
7. Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry. 2005;57(11):1336-1346.
8. Nigg JT. Neuropsychologic theory and findings in attention-deficit/ hyperactivity disorder: the state of the field and salient challenges for the coming decade. Biol Psychiatry. 2005;57(11):1424-1435.
9. Seidman LJ, Valera EM, Makris N. Structural brain imaging of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57(11): 1263-1272.
10. Bush G, Valera EM, Seidman LJ. Functional neuroimaging of attention- deficit/hyperactivity disorder: a review and suggested future directions. Biol Psychiatry. 2005;57(11):1273-1284.
11. Friedman LA, Rapoport JL. Brain development in ADHD. Curr Opin Neurobiol. 2015;30:106-111.
12. Russ SA, Larson K, Halfon N. A national profile of childhood epilepsy and seizure disorder. Pediatrics. 2012;129(2):256-264.
13. Reilly C, Atkinson P, Das KB, et al. Neurobehavioral comorbidities in children with active epilepsy: a population-based study. Pediatrics. 2014;133(6):e1586-e1593.
14. Cohen R, Senecky Y, Shuper A, et al. Prevalence of epilepsy and attention-deficit hyperactivity (ADHD) disorder: a population-based study. J Child Neurol. 2013;28(1):120-123.
15. Dunn DW, Austin JK, Harezlak J, Ambrosius WT. ADHD and epilepsy in childhood. Dev Med Child Neurol. 2003;45(1):50-54.
16. Gonzalez-Heydrich J, Hsin O, Gumlak S, et al. Comparing stimulant effects in youth with ADHD symptoms and epilepsy. Epilepsy Behav. 2014;36:102-107.
17. Hesdorffer DC, Ludvigsson P, Olafsson E, et al. ADHD as a risk factor for incident unprovoked seizures and epilepsy in children. Arch Gen Psychiatry. 2004;61(7):731-736.
18. Gonzalez-Heydrich J, Dodds A, Whitney J, et al. Psychiatric disorders and behavioral characteristics of pediatric patients with both epilepsy and attention-deficit hyperactivity disorder. Epilepsy Behav. 2007;10(3):384-388.
19. Hermann B, Jones J, Dabbs K, et al. The frequency, complications and aetiology of ADHD in new onset paediatric epilepsy. Brain. 2007; 130(pt 12):3135-3148.
20. Sherman EM, Slick DJ, Connolly MB, Eyrl KL. ADHD, neurological correlates and health-related quality of life in severe pediatric epilepsy. Epilepsia. 2007;48(6):1083-1091.
21. Bechtel N, Weber P. Attention problems in children with epilepsy. How is the long-term outcome? Eur JPaediatr Neurol. 2015;19(3):383-385.
22. Austin JK, Harezlak J, Dunn DW, Huster GA, Rose DR, Ambrosius WT. Behavior problems in children prior to first recognized seuzures. Pediatrics. 2001;107:115-122.
23. Reilly C, Atkinson P, Das KB, et al. Parent- and teacher-reported symptoms of ADHD in school-aged children with active epilepsy: a population-based study. J Atten Disord. 2014 Epub Nov 21.
24. Fastenau PS, Jianzhao S, Dunn DW, Austin JK. Academic underachievement among children with epilepsy: proportion exceeding psychometric criteria for learning disability and associated risk factors. J Learn Disabil 2008;41(3):195-207.
25. Hermann BP, Jones JE, Sheth R, et al. Growing up with epilepsy: a two-year investigation of cognitive development in children with new onset epilepsy. Epilepsia. 2008;49(11):1847-1858.
26. Reilly C, Atkinson P, Das KB, et al. Academic achievement in school- aged children with active epilepsy: a population-based study. Epilepsia. 2014;55(12):1910-1917.
27. Yoong M. Quantifying the deficit-imaging neurobehavioural impairment in childhood epilepsy. Quant Imaging Med Surg. 2015;5(2): 225-237.
28. Triplett RL, Asato MR. Brief cognitive and behavioral screening in children with new-onset epilepsy: a pilot feasibility trial. Pediatr Neurol. 2015;52(1):49-55.
29. Stiers P, Fonteyne A, Wouters H, D’Agostino E, Sunaert S, Lagae L. Hippocampal malrotation in pediatric patients with epilepsy associated with complex prefrontal dysfunction. Epilepsia. 2010;51(4):546-555.
30. Sanchez-Carpintero R, Neville BG. Attentional ability in children with epilepsy. Epilepsia. 2003;44(10):1340-1349.
31. Kang SH, Yum MS, Kim EH, Kim HW, Ko TS. Cognitive function in childhood epilepsy: importance of attention deficit hyperactivity disorder. J Clin Neurol. 2015;11(1):20-25.
32. Reilly C, Atkinson P, Das KB, et al. Cognition in school-aged children with “active” epilepsy: a population-based study. J Clin Exp Neuropsychol. 2015;37(4):429-438.
33. Berl MM, Terwilliger V, Scheller A, Sepeta L, Walkowiak J, Gaillard WD. Speed and complexity characterize attention problems in children with localization-related epilepsy. Epilepsia. 2015; 56(6):833-840.
34. Hernandez MT, Sauerwein HC, Jambaque I, et al. Attention, memory, and behavioral adjustment in children with frontal lobe epilepsy. Epilepsy Behav. 2003;4(5):522-536.
35. Gottlieb L, Zelko FA, Kim DS, Nordli DR. Cognitive proficiency in pediatric epilepsy. Epilepsy Behav. 2012;23(2):146-151.
36. Almane D, Jones JE, Jackson DC, Seidenberg M, Hermann BP. The social competence and behavioral problem substrate of new- and recent- onset childhood epilepsy. Epilepsy Behav. 2014;31:91-96.
37. Jones JE, Watson R, Sheth R, et al. Psychiatric comorbidity in children with new onset epilepsy. Dev Med Child Neurol. 2007;49(7): 493-497.
38. Pineda E, Jentsch JD, Shin D, Griesbach G, Sankar R, Mazarati A. Behavioral impairments in rats with chronic epilepsy suggest comorbidity between epilepsy and attention deficit/hyperactivity disorder. Epilepsy Behav. 2014;31:267-275.
39. Hernan AE, Alexander A, Jenks KR, et al. Focal epileptiform activity in the prefrontal cortex is associated with long-term attention and sociability deficits. NeurobiolDis. 2014;63:25-34.
40. Davies S, Heyman I, Goodman R. A population survey of mental health problems in children with epilepsy. Dev Med Child Neurol. 2003;45(5):292-295.
41. McCusker CG, Kennedy PJ, Anderson J, Hicks EM, Hanrahan D. Adjustment in children with intractable epilepsy: importance of seizure duration and family factors. Dev Med Child Neurol. 2002;44(10): 681-687.
42. Kwan P, Brodie MJ. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet. 2001;357(9251):216-222.
43. Bourgeois BF. Determining the effects of antiepileptic drugs on cognitive function in pediatric patients with epilepsy. J Child Neurol. 2004;19(suppl 1):S15-S24.
44. Loring DW, Meador KJ. Cognitive side effects of antiepileptic drugs in children. Neurology. 2004;62(6):872-877.
45. Gillham RA, Williams N, Wiedmann K, Butler E, Larkin JG, Brodie MJ. Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients. J Neurol Neurosurg Psychiatry. 1988;51(7):929-933.
46. Brodie MJ, McPhail E, Macphee GJ, Larkin JG, Gray JM. Psychomotor impairment and anticonvulsant therapy in adult epileptic patients. Eur J Clin Pharmacol. 1987;31(6):655-660.
47. Oostrom KJ, Schouten A, Kruitwagen CL, Peters AC, Jennekens- Schinkel A. Attention deficits are not characteristic of schoolchildren with newly diagnosed idiopathic or cryptogenic epilepsy. Epilepsia. 2002;43(3):301-310.
48. Pliszka S, Issues AWGoQ. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894-921.
49. Subcommittee on Attention-Deficit/Hyperactivity Disorder; Steering Committee on Quality Improvement and Management, Wolraich M, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007—1022.
50. Pliszka SR, Crismon ML, Hughes CW, et al. The Texas Children’s Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006;45(6):642-657.
51. Torres AR, Whitney J, Gonzalez-Heydrich J. Attention-deficit/ hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment. Epilepsy Behav. 2008;12(2):217-233.
52. Kuczenski R, Segal DS. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem. 1997;68(5):2032-2037.
53. Sulzer D, Sonders MS, Poulsen NW, Galli A. Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol. 2005;75(6):406-433.
54. Spencer TJ, Abikoff HB, Connor DF, et al. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/ hyperactivity disorder in school-aged children and adolescents: a 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study. Clin Ther. 2006; 28(3):402-418.
55. McGough J, McCracken J, Swanson J, et al. Pharmacogenetics of methylphenidate response in preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry. 2006;45(11):1314-1322.
56. Wigal T, Greenhill L, Chuang S, et al. Safety and tolerability of methylphenidate in preschool children with ADHD. J Am Acad Child Adolesc Psychiatry. 2006;45(11):1294—1303.
57. Michelson D, Allen AJ, Busner J, et al. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry. 2002;159(11):1896-1901.
58. Faraone SV, Biederman J, Spencer TJ, Aleardi M. Comparing the efficacy of medications for ADHD using meta-analysis. MedGenMed. 2006;8(4):4.
59. Newcorn JH, Kratochvil CJ, Allen AJ, et al. Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response. Am J Psychiatry. 2008;165(6):721-730.
60. Geller D, Donnelly C, Lopez F, et al. Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(9):1119-1127.
61. Sallee F, Connor DF, Newcorn JH. A review of the rationale and clinical utilization of alpha2-adrenoceptor agonists for the treatment of attention-deficit/hyperactivity and related disorders. J Child Adolesc Psychopharmacol. 2013;23(5):308-319.
62. Ruggiero S, Clavenna A, Reale L, Capuano A, Rossi F, Bonati M. Guanfacine for attention deficit and hyperactivity disorder in pediatrics: a systematic review and meta-analysis. Eur Neuropsychopharmacol. 2014;24(10):1578-1590.
63. Findling RL, McBurnett K, White C, Youcha S. Guanfacine extended release adjunctive to a psychostimulant in the treatment of comorbid oppositional symptoms in children and adolescents with attention- deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2014;24(5):245-252.
64. Gross-Tsur V, Manor O, van der Meere J, Joseph A, Shalev RS. Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective? J Pediatr. 1997;130(4):670-674.
65. Hemmer SA, Pasternak JF, Zecker SG, Trommer BL. Stimulant therapy and seizure risk in children with ADHD. Pediatr Neurol. 2001;24(2):99-102.
66. Feldman H, Crumrine P, Handen BL, Alvin R, Teodori J. Methylphenidate in children with seizures and attention-deficit disorder. Am J Dis Child. 1989;143(9):1081-1086.
67. Baptista-Neto L, Dodds A, Rao S, Whitney J, Torres A, Gonzalez- Heydrich J. An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy. Expert Opin Investig Drugs. 2008;17(1):77-84.
68. Van-der Feltz-Cornelis CM, Aldenkamp AP. Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial. Epilepsy Behav. 2006; 8(3):659-662.
69. Gonzalez-Heydrich J, Whitney J, Waber D, et al. Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy. Epilepsy Behav. 2010;18(3):229-237.
70. Gucuyener K, Erdemoglu AK, Senol S, Serdaroglu A, Soysal S, Kockar AI. Use of methylphenidate for attention-deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities. J Child Neurol. 2003;18(2):109-112.
71. Koneski JA, Casella EB. Attention deficit and hyperactivity disorder in people with epilepsy: diagnosis and implications to the treatment. Arq Neuropsiquiatr. 2010;68(1):107-114.
72. Santos K, Palmini A, Radziuk AL, et al. The impact of methylphenidate on seizure frequency and severity in children with attention-deficit hyperactivity disorder and difficult-to-treat epilepsies. Dev Med Child Neurol. 2013;55(7):654-660.
73. Fosi T, Lax-Pericall MT, Scott RC, Neville BG, Aylett SE. Methylphenidate treatment of attention deficit hyperactivity disorder in young people with learning disability and difficult-to-treat epilepsy: evidence of clinical benefit. Epilepsia. 2013;54(12):2071-2081.
74. Radziuk AL, Kieling RR, Santos K, Rotert R, Bastos F, Palmini AL. Methylphenidate improves the quality of life of children and adolescents with ADHD and difficult-to-treat epilepsies. Epilepsy Behav. 2015;46:215-220.
75. Wernicke JF, Holdridge KC, Jin L, et al. Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine. Dev Med Child Neurol. 2007;49(7):498-502.
76. Torres A, Whitney J, Rao S, Tilley C, Lobel R, Gonzalez-Heydrich J. Tolerability of atomoxetine for treatment of pediatric attention-deficit/ hyperactivity disorder in the context of epilepsy. Epilepsy Behav. 2011;20(1):95-102.
77. Scaramuzza A, Torresani P, Arisi D, Rossoni R. Seizures following clo- nidine test for growth hormone reserve: unusual presentation of benign partial epilepsy. J Pediatr Endocrinol Metab. 2000;13(4):451-452.
78. MacFaul R, Miller G. Clonidine poisoning in children. Lancet. 1977; 1(8024):1266-1267.
79. Hunyor SN, Bradstock K, Somerville PJ, Lucas N. Clonidine overdose. Br Med J. 1975;4(5987):23.
80. Cantwell DP, Swanson J, Connor DF. Case study: adverse response to clonidine. J Am Acad Child Adolesc Psychiatry. 1997;36(4): 539-544.
81. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999;56(12):1073-1086.
82. Barkley RA. Taking Charge of ADHD: The Complete, Authoritative Guide for Parents. Rev. ed. New York: Guilford Press; 2000.
83. Triplett RL, Velanova K, Luna B, Padmanabhan A, Gaillard WD, Asato MR. Investigating inhibitory control in children with epilepsy: an fMRI study. Epilepsia. 2014;55(10):1667-1676.
84. Sayal K, Washbrook E, Propper C. Childhood behavior problems and academic outcomes in adolescence: longitudinal population- based study. J Am Acad Child Adolesc Psychiatry. 2015;54(5): 360.e-368.e.